chrX-65488991-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001010888.4(ZC3H12B):c.190G>A(p.Asp64Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000413 in 1,209,380 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010888.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC3H12B | NM_001010888.4 | c.190G>A | p.Asp64Asn | missense_variant | 6/10 | ENST00000338957.5 | NP_001010888.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC3H12B | ENST00000338957.5 | c.190G>A | p.Asp64Asn | missense_variant | 6/10 | 1 | NM_001010888.4 | ENSP00000340839 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111364Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33562
GnomAD3 exomes AF: 0.0000166 AC: 3AN: 180931Hom.: 0 AF XY: 0.0000298 AC XY: 2AN XY: 67007
GnomAD4 exome AF: 0.0000428 AC: 47AN: 1098016Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 19AN XY: 363448
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111364Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33562
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2023 | The c.190G>A (p.D64N) alteration is located in exon 1 (coding exon 1) of the ZC3H12B gene. This alteration results from a G to A substitution at nucleotide position 190, causing the aspartic acid (D) at amino acid position 64 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at